Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

Cipla Ltd.

BSE: 500087 | NSE: CIPLA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE059A01026 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Mar 23, 16:01
1222.70 -33.15 (-2.64%)
Volume
AVERAGE VOLUME
5-Day
40,263
10-Day
47,290
30-Day
64,804
64,798
  • Prev. Close

    1255.85

  • Open Price

    1255.95

  • Bid Price (Qty.)

    1215.10 (10)

  • Offer Price (Qty.)

    1220.00 (17)

NSE Live

Mar 23, 15:59
1221.80 -34.60 (-2.75%)
Volume
AVERAGE VOLUME
5-Day
1,557,652
10-Day
1,435,505
30-Day
1,496,509
1,295,463
  • Prev. Close

    1256.40

  • Open Price

    1252.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1221.80 (3203)

Financials

Profit & Loss account of Cipla (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 12,220.22 11,968.44 11,004.44 10,637.08 11,873.46  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 54.91 206.09 0.00  
Revenue From Operations [Net] 12,220.22 11,968.44 10,949.53 10,430.99 11,873.46  
Total Operating Revenues 12,659.15 12,374.01 11,389.90 10,768.49 12,117.72  
Other Income 892.85 577.52 334.88 129.85 280.30  
Total Revenue 13,552.00 12,951.53 11,724.78 10,898.34 12,398.02  
EXPENSES  
Cost Of Materials Consumed 2,999.17 3,112.25 3,303.31 2,956.04 3,633.34  
Purchase Of Stock-In Trade 1,363.12 1,259.21 1,064.23 1,128.99 1,037.56  
Operating And Direct Expenses 0.00 0.00 475.13 443.37 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -43.08 136.70 -212.05 56.27 228.35  
Employee Benefit Expenses 1,911.08 1,839.84 1,785.94 1,728.97 1,778.56  
Finance Costs 36.05 16.97 11.90 39.20 147.07  
Depreciation And Amortisation Expenses 599.78 569.72 529.61 499.97 442.69  
Other Expenses 3,721.57 3,524.01 2,777.79 2,858.59 3,386.48  
Total Expenses 10,587.69 10,458.70 9,735.86 9,711.40 10,654.05  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 2,964.31 2,492.83 1,988.92 1,186.94 1,743.97  
Exceptional Items 0.00 0.00 -77.52 0.00 0.00  
Profit/Loss Before Tax 2,964.31 2,492.83 1,911.40 1,186.94 1,743.97  
Tax Expenses-Continued Operations  
Current Tax 545.96 576.43 431.33 311.06 356.64  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax 100.18 27.99 11.55 -99.06 -74.97  
Tax For Earlier Years 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 646.14 604.42 442.88 212.00 281.67  
Profit/Loss After Tax And Before ExtraOrdinary Items 2,318.17 1,888.41 1,468.52 974.94 1,462.30  
Profit/Loss From Continuing Operations 2,318.17 1,888.41 1,468.52 974.94 1,462.30  
Profit/Loss For The Period 2,318.17 1,888.41 1,468.52 974.94 1,462.30  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 28.76 23.45 18.25 12.13 18.21  
Diluted EPS (Rs.) 28.72 23.41 18.22 12.11 18.16  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 0.00  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 0.00  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 564.26 241.57 160.94 160.87 180.92  
Tax On Dividend 87.45 40.40 28.33 32.71 0.00  
Equity Dividend Rate (%) 200.00 150.00 150.00 100.00 100.00  
Source : Dion Global Solutions Limited

Results of Cipla

Results of Pharmaceuticals Sector

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347